Issues

First issue features:

  • Our first overview article published in Toxicologic Pathology
  • Key regulatory discussions, including engagement with major regulatory authorities
  • Highlights from our first public webinars, with more than 170 and 120 participants
  • Meet the people behind VICT3R in our new interview series
  • Expanding industry and academic collaborations to advance VCGs

Check out the web version.